The $160 Touchoint is advertised to reduce stress, a useful tool at a chaotic show like CES. In technical terms, the devices provide “bilateral alternating stimulation in tactile (BLAST) form technology,” and the company cites a research article from the Journal of Biotechnology and Biomedical Science that it “has been shown to modulate the electrical activity of brain networks that mediate the stress response, resulting in a stress-reducing effect in individuals with high reported levels of anxiety.”
Here’s my short interview with Touchpoint CEO and Founder Vicky Mayo